Join
Live feed
·
PRReleasevia Quantisnow
Novan Inc. logo

Novan Announces Publication of Positive Results from Pivotal Phase 3 Study of Berdazimer Gel, 10.3% (SB206) in Patients with Molluscum Contagiosum in JAMA Dermatology

ByQuantisnow·Wall Street's wire, on your screen.
NOVN· Novan Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NOVN (Novan Inc.) and more on Quantisnow.